Minding - you're welcome and it's my pleasure to provide the information. I enjoy being a moderator for this site and company because I feel this is a hidden gem.... the company has no debt for starters and doesn't need to dilute for capital. in addition to that, the therapy is proven and is getting huge attention within the ALS community. as I've stated before, if I make a huge profit on this, I plan to donate most of my gains to ALS research. I'd really like to donate it back to this company as they make significant progress in ALS and in other areas.
in my opinion - this company is a game changer and there's a huge upside over the next several years. I think the stock price will range between $2.40-2.80's over the next month or so unless there is really good news released, then we'll break through $3. I plan to add more to my pile as well. currently I have 3500 shares at an average price $2.72 and if it dips into $2.50's, i'll buy more. the stock won't be too exciting as they go through the phase 3 process but as the CEO stated, they don't plan to raise capital for phase 3 which means, they're very confident that they'll have plenty of money for phase 3. I really like the CEO, he's no BS, straight to the point, and very transparent. look for more detailed news about phase 3 plans and second indicator being used for MS study.
good luck to you!
News 
Market Data 
Discover 
